Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$728M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$645M |
| 3 |
SPDR Gold Trust
GLD
|
+$413M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$401M |
| 5 |
SpaceX
SPCX
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.91B |
| 2 |
Micron Technology
MU
|
+$1.85B |
| 3 |
NVIDIA
NVDA
|
+$1.69B |
| 4 |
GE Vernova
GEV
|
+$809M |
| 5 |
Advanced Micro Devices
AMD
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.44% |
| 2 | Technology | 22.37% |
| 3 | Financials | 6.09% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Healthcare | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
Vitesse Energy
VTS
$611M
| $1.52M | ﹤0.01% |
91,123
+71,864
| +373% | +$1.19M |
2023 Q1
14 quarters
|
|
2952
National Bank Holdings
NBHC
$1.7B
| $1.52M | ﹤0.01% |
38,795
-12,776
| -25% | -$544K |
2013 Q2
53 quarters
|
|
2953
Vanguard Utilities ETF
VPU
$8.49B
| $1.52M | ﹤0.01% |
8,884
+1,098
| +14% | +$206K |
2013 Q2
53 quarters
|
|
2954
Teleflex
TFX
$6.35B
| $1.52M | ﹤0.01% |
12,135
+6,951
| +134% | +$928K |
2013 Q2
53 quarters
|
|
2955
Douglas Emmett
DEI
$1.77B
| $1.52M | ﹤0.01% |
158,184
-55,374
| -26% | -$636K |
2013 Q2
53 quarters
|
|
2956
Piper Sandler
PIPR
$4.94B
| $1.51M | ﹤0.01% |
22,960
-23,391
| -50% | -$1.74M |
2013 Q2
53 quarters
|
|
2957
Huntsman Corp
HUN
$1.71B
| $1.51M | ﹤0.01% |
179,701
-37,389
| -17% | -$385K |
2013 Q2
53 quarters
|
|
2958
Legend Biotech
LEGN
$4.51B
| $1.51M | ﹤0.01% |
75,885
+19,638
| +35% | +$419K |
2020 Q4
23 quarters
|
|
2959
Upwork
UPWK
$1.29B
| $1.5M | ﹤0.01% |
184,369
+70,337
| +62% | +$621K |
2018 Q4
31 quarters
|
|
2960
CALL
D.R. Horton
DHI
$42.8B
| $1.5M | ﹤0.01% |
11,000
| – | – |
2026 Q2
1 quarter
|
|
2961
Recursion Pharmaceuticals
RXRX
$2.32B
| $1.5M | ﹤0.01% |
363,644
-500,759
| -58% | -$1.7M |
2021 Q2
21 quarters
|
|
2962
BeOne Medicines Ltd
ONC
$42.8B
| $1.5M | ﹤0.01% |
4,103
-757
| -16% | -$259K |
2016 Q4
39 quarters
|
|
2963
Caleres
CAL
$503M
| $1.5M | ﹤0.01% |
123,008
+104,120
| +551% | +$1.31M |
2013 Q2
53 quarters
|
|
2964
Baytex Energy
BTE
$3.11B
| $1.5M | ﹤0.01% |
330,782
+271,013
| +453% | +$1.22M |
2026 Q1
2 quarters
|
|
2965
Nuveen ESG US Aggregate Bond ETF
NUBD
$494M
| $1.5M | ﹤0.01% |
70,730
+2,523
| +4% | +$54.8K |
2025 Q1
6 quarters
|
|
2966
Stagwell
STGW
$2.79B
| $1.5M | ﹤0.01% |
183,916
+130,549
| +245% | +$1.09M |
2021 Q2
21 quarters
|
|
2967
State Street SPDR Portfolio Aggregate Bond Index ETF
SPAB
$10.4B
| $1.49M | ﹤0.01% |
61,254
+3,116
| +5% | +$78K |
2013 Q2
53 quarters
|
|
2968
John Hancock Multifactor Emerging Markets ETF
JHEM
$916M
| $1.49M | ﹤0.01% |
37,593
| – | – |
2026 Q2
1 quarter
|
|
2969
Fervo Energy
FRVO
$2.64B
| $1.49M | ﹤0.01% |
109,481
+100,304
| +1,093% | +$2.03M |
2026 Q2
1 quarter
|
|
2970
iShares Global Financials ETF
IXG
$725M
| $1.49M | ﹤0.01% |
11,708
+620
| +6% | +$81.9K |
2017 Q1
38 quarters
|
|
2971
iShares International Treasury Bond ETF
IGOV
$1.04B
| $1.49M | ﹤0.01% |
37,355
+3,759
| +11% | +$154K |
2015 Q4
43 quarters
|
|
2972
Lamb Weston
LW
$7.78B
| $1.48M | ﹤0.01% |
35,562
-180,510
| -84% | -$8.95M |
2016 Q4
39 quarters
|
|
2973
Lakeland Financial Corp
LKFN
$1.56B
| $1.48M | ﹤0.01% |
25,684
-219
| -0.8% | -$13.3K |
2013 Q2
53 quarters
|
|
2974
BioCryst Pharmaceuticals
BCRX
$2.14B
| $1.48M | ﹤0.01% |
177,184
-183,005
| -51% | -$1.72M |
2013 Q2
53 quarters
|
|
2975
Global E Online
GLBE
$7.54B
| $1.48M | ﹤0.01% |
37,138
+23,429
| +171% | +$912K |
2021 Q2
21 quarters
|
|
Similar funds
Citigroup's Q3 2026 Portfolio in Review
As of Q3 2026, Citigroup held 6,419 positions worth $308B, up 1.8% from $303B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2026 filing shows 741 new, 2,043 increased, 2,737 reduced and 437 closed positions. Its largest new stake was SK Hynix Inc: 1,085,406 shares worth $200M. The largest sale was Microsoft, an estimated $1.91B.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q3 2026 buy was SK Hynix Inc: 1,085,406 shares worth $200M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $728M increase.
- Citigroup's biggest Q3 2026 reduction was Microsoft, cutting an estimated $1.91B.
- Citigroup fully exited Webster Financial in Q3 2026, selling an estimated $273M.
- Citigroup's ten largest holdings make up 21% of its $308B portfolio in Q3 2026.
- Citigroup opened 741 new positions and closed 437 in Q3 2026.
- Citigroup's portfolio value rose 1.8% quarter-over-quarter to $308B.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.